WATSON LABS INC FDA Approval ANDA 200431

ANDA 200431

WATSON LABS INC

FDA Drug Application

Application #200431

Application Sponsors

ANDA 200431WATSON LABS INC

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004
Discontinued005

Application Products

001TABLET, EXTENDED RELEASE;ORALEQ 2MG BASE0ROPINIROLE HYDROCHLORIDEROPINIROLE HYDROCHLORIDE
002TABLET, EXTENDED RELEASE;ORALEQ 4MG BASE0ROPINIROLE HYDROCHLORIDEROPINIROLE HYDROCHLORIDE
003TABLET, EXTENDED RELEASE;ORALEQ 6MG BASE0ROPINIROLE HYDROCHLORIDEROPINIROLE HYDROCHLORIDE
004TABLET, EXTENDED RELEASE;ORALEQ 8MG BASE0ROPINIROLE HYDROCHLORIDEROPINIROLE HYDROCHLORIDE
005TABLET, EXTENDED RELEASE;ORALEQ 12MG BASE0ROPINIROLE HYDROCHLORIDEROPINIROLE HYDROCHLORIDE

FDA Submissions

N/A; Not ApplicableORIG1AP2012-06-06

Submissions Property Types

ORIG1Null15

CDER Filings

WATSON LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 200431
            [companyName] => WATSON LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ROPINIROLE HYDROCHLORIDE","activeIngredients":"ROPINIROLE HYDROCHLORIDE","strength":"EQ 2MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ROPINIROLE HYDROCHLORIDE","activeIngredients":"ROPINIROLE HYDROCHLORIDE","strength":"EQ 4MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ROPINIROLE HYDROCHLORIDE","activeIngredients":"ROPINIROLE HYDROCHLORIDE","strength":"EQ 6MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ROPINIROLE HYDROCHLORIDE","activeIngredients":"ROPINIROLE HYDROCHLORIDE","strength":"EQ 8MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ROPINIROLE HYDROCHLORIDE","activeIngredients":"ROPINIROLE HYDROCHLORIDE","strength":"EQ 12MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/06\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2012-06-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.